ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,799.64
0.11%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
02/06/202416:00PR Newswire (Canada)Media Advisory - Deputy Prime Minister's itinerary for Monday, June 3, 2024
02/06/202416:00PR Newswire (Canada)Avis aux médias - Itinéraire de la vice-première ministre pour le lundi 3 juin 2024
02/06/202415:35CointelegraphUS Navy launches ‘PARANOID’ blockchain security tech to private sectorCOIN:BTCUSDBitcoin
02/06/202415:08GlobeNewswire Inc.In occasione di ASMS 2024, Biognosys lancia la rivoluzionaria tecnologia P2 Plasma Enrichment per la proteomica del plasma profonda e imparziale
02/06/202415:08GlobeNewswire Inc.Biognosys lance P2 Plasma Enrichment, une technologie révolutionnaire pour la protéomique approfondie et non biaisée du plasma à la conférence de l’ASMS 2024
02/06/202415:08GlobeNewswire Inc.Biognosys stellt auf der ASMS 2024 die bahnbrechende P2 Plasma-Anreicherungstechnologie für unverfälschte, tiefgehende Plasmaproteomik vor
02/06/202415:08GlobeNewswire Inc.Biognosys lanza en la conferencia anual de la ASMS 2024 la innovadora tecnología de enriquecimiento plasmático P2 para una proteómica plasmática profunda e imparcial
02/06/202415:00The Daily HodlTrader That Called May 2021 Crypto Collapse Unveils Potential Max Target for Bitcoin Bull Market TopCOIN:BTCUSDBitcoin
02/06/202415:00PR Newswire (US)FrogData Unveils Major AI Factory Upgrade to Revolutionize Automotive Retail Operations
02/06/202414:52ZyCryptoAmerica’s Wealthiest Prisoner: Former Binance CEO CZ Starts Four-Month Jail SentenceCOIN:FETUSDFetch
02/06/202414:47ZyCrypto$1 XRP Price Nigh as Ripple’s Move To Become Stablecoin Giant Proves Weighty with Whales Moving MillionsCOIN:XRPUSDRipple
02/06/202414:45PR Newswire (US)izmostock Unveils Revolutionary Image Solution for Leasing Industry, Driving Unparalleled ROI and User Engagement
02/06/202414:01The Daily Hodl$517,000,000,000 in Unrealized Losses Hit US Banking System As FDIC Warns 63 Lenders on Brink of InsolvencyCOIN:FETUSDFetch
02/06/202414:00PR Newswire (Canada)Conférence de presse du ministre de la Justice et du ministre de la Sécurité publique
02/06/202413:53PR Newswire (US)GIGABYTE Partners with NVIDIA on RTX AI PCs Supporting ACE NIM and Digital Human Technology
02/06/202413:45The Daily HodlVitalik Buterin Donates 30 Ethereum (ETH) to Tornado Cash Developers’ Legal Fund: On-Chain DataCOIN:ETHUSDEthereum
02/06/202413:32Business WireTAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trialNASDAQ:AZNAstraZeneca PLC
02/06/202413:23PR Newswire (Canada)AVIS - Voie de contournement ferroviaire à Lac-Mégantic: point de presse de Christine Labrie et de groupes de la société civile
02/06/202413:20ZyCryptoBullish Optimism Soars as Dogecoin Whales Splash $112 Million In 72-Hour Buying SpreeCOIN:DOGEUSDDogecoin
02/06/202412:29ZyCryptoBlockDAG Excels with $39M Presale, Outperforming NEAR, and AvalancheCOIN:DOGEUSDDogecoin
02/06/202412:28ZyCryptoBlockDAG Excels with Innovative Dashboard and $39M Presale, Surpassing TRON and BNBCOIN:AVAXUSDAvalanche
02/06/202412:05CointelegraphBNB, AR, XMR, and TIA set to rally — Will Bitcoin's $70K breakout be the trigger?COIN:XMRUSDMonero
02/06/202412:00PR Newswire (Canada)/R E P E A T -- Media Advisory - Minister Wilkinson announces funding and measures to protect Southern Resident killer whales/
02/06/202412:00PR Newswire (Canada)/R E P R I S E -- Avis aux médias - Le ministre Wilkinson annonce des investissements et des mesures pour protéger les épaulards résidents du Sud/
02/06/202411:55The Daily HodlSenator Cynthia Lummis Blasts Biden Administration Following President’s Decision To Veto SEC-Related Crypto BillCOIN:FETUSDFetch
02/06/202411:48The Daily HodlBank Manager Steals $208,939 From Customer, Extracts Money From Accounts Despite Victim’s Demise: US Department of JusticeCOIN:BTCUSDBitcoin
02/06/202411:44CointelegraphMeta’s AI chief slams Elon Musk over hype, conspiracy theoriesCOIN:BTCUSDBitcoin
02/06/202411:30GlobeNewswire Inc.Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 2024 ASCO® Annual MeetingNASDAQ:MRUSMerus NV
02/06/202411:30GlobeNewswire Inc.Merus : présentation des données provisoires sur le MCLA-145 en monothérapie et en association avec le pembrolizumab lors du congrès annuel 2024 de l’ASCO®TG:2GHMerus NV
02/06/202411:30Business WireCatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination

Su Consulta Reciente

HITB
MULTIUSDT
Multichain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados